Haemonetics (HAE) Tops Q2 EPS by 2c, Revenues Beat
Tweet
Share
E-mailGet Alerts HAE Hot Sheet
Price: $72.78 +0.34%
EPS Growth %: -0.9%
Financial Fact:
Provision for income taxes: 3M
Today's EPS Names:
CBRS, MAYS, CRMT, More
EPS Growth %: -0.9%
Financial Fact:
Provision for income taxes: 3M
Today's EPS Names:
CBRS, MAYS, CRMT, More
Join SI Premium – FREE
Haemonetics (NYSE: HAE) reported Q2 EPS of $0.56, $0.02 better than the analyst estimate of $0.54. Revenue for the quarter came in at $242 million versus the consensus estimate of $233.45 million.
For earnings history and earnings-related data on Haemonetics (HAE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- FedEx (FDX) Tops Q4 EPS by 39c, Beats on Revenue; Offers FY27 EPS Guidance
- Nike names former Pfizer CFO David Denton as new finance chief
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
